Zhang Huihui, Shen Ying, Bai Peijian, Wu Xiaorui, Li Ping, Wang Ting
Oncology Department of Integrated Traditional Chinese and Western Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei, 230001, China.
National Clinical Research Center for Hematologic Disease, Institute of Blood and Marrow Transplantation of Soochow University, The First Affiliated Hospital of Soochow University, Suzhou, 215006, China.
Discov Oncol. 2025 Jun 3;16(1):989. doi: 10.1007/s12672-025-02824-5.
Matrix remodeling-associated 7 (MXRA7) plays a key role in physiological and pathological processes involving the extracellular matrix (ECM) and tissue remodeling. Recent studies have highlighted its functions in tissue injury, immune response, and cellular differentiation, yet no bibliometric studies have systematically mapped MXRA7 research. This study evaluates global MXRA7 research from 2015 to 2024 to identify current trends and future directions.
A comprehensive bibliometric analysis was conducted using the Web of Science Core Collection. We examined publication trends, geographical contributions, influential authors, and high-impact journals, identifying research hotspots and emerging trends with advanced bibliometric tools.
Analysis of 553 English-language publications showed that MXRA7 research has progressed significantly after 2017, showing a general upward trend accompanied by short-term fluctuations. The United States leads, followed by China and the United Kingdom. Key studies appear in high-impact journals like PLOS ONE, and influential authors such as Frangogiannis NG have propelled the field. Keywords including "inflammation", "extracellular matrix", "matrix metalloproteinases" and "angiogenesis" underscore MXRA7's roles in immune responses, tissue repair, and fibrosis.
This analysis shows significant growth in MXRA7 research, especially in inflammation, ECM remodeling, and tissue regeneration. Future work should explore MXRA7's molecular mechanisms in immune diseases, fibrosis, and cancer, advancing its potential as a therapeutic target.
基质重塑相关蛋白7(MXRA7)在涉及细胞外基质(ECM)和组织重塑的生理和病理过程中起关键作用。最近的研究突出了其在组织损伤、免疫反应和细胞分化中的功能,但尚无文献计量学研究系统地梳理MXRA7的研究情况。本研究评估了2015年至2024年全球范围内的MXRA7研究,以确定当前趋势和未来方向。
使用科学网核心合集进行了全面的文献计量分析。我们研究了发表趋势、地域贡献、有影响力的作者和高影响力期刊,运用先进的文献计量工具确定研究热点和新兴趋势。
对553篇英文出版物的分析表明,2017年后MXRA7研究取得了显著进展,呈总体上升趋势并伴有短期波动。美国领先,其次是中国和英国。关键研究发表在如《公共科学图书馆·综合》等高影响力期刊上,像弗兰戈吉安尼斯·N·G等有影响力的作者推动了该领域的发展。包括“炎症”“细胞外基质”“基质金属蛋白酶”和“血管生成”等关键词突显了MXRA7在免疫反应、组织修复和纤维化中的作用。
该分析表明MXRA7研究显著增长,尤其是在炎症、ECM重塑和组织再生方面。未来的工作应探索MXRA7在免疫疾病、纤维化和癌症中的分子机制,提升其作为治疗靶点的潜力。